PWP vs REGN · rev $878.0M vs P/E 14, rev $14.34B
Perella Weinberg Partners (PWP) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Perella Weinberg Partners (PWP) is a capital markets company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported PWP revenue for 2024-12-31 was $878.0M. Net income was -$89.3M. Revenue was up 35.4% from 2023-12-31 to 2024-12-31. PWP currently screens at market cap $1.82B.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
PWP currently screens at market cap $1.82B. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the PWP and REGN stock pages for the full models.
Not investment advice.